Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects
Drug Design, Development and Therapy · 2025-10 · Volume 19 · 9227-9234
DOI: 10.2147/dddt.s550126 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025-10. Verfasst von Jaegu Kang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
ORCID-Profile: Jaegu Kang, Sungyeun Bae, Kyung-Sang Yu, SeungHwan Lee
Zitieren
APA
Kang, J., Bae, S., Yu, K. S., & Lee, S. (2025). Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects. Drug Design, Development and Therapy, Volume 19, 9227-9234. https://doi.org/10.2147/dddt.s550126
Vancouver
Kang J, Bae S, Yu KS, Lee S. Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects. Drug Design, Development and Therapy. 2025;Volume 19:9227-9234. doi:10.2147/dddt.s550126
BibTeX
@article{Kang2025,
author = {Kang, Jaegu and Bae, Sungyeun and Yu, Kyung-Sang and Lee, SeungHwan},
title = {Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {9227--9234},
doi = {10.2147/dddt.s550126}
}
EUVIMED